The All Ireland Cooperative Oncology Research Group – Developmental Therapeutics Review – Q4 2010
Summary
Global Market Direct’s pharmaceuticals report, “The All Ireland Cooperative Oncology Research Group – Developmental Therapeutics Review – Q4 2010” provides data on the institute’s research and development focus. The report includes information on therapeutics under development, complete with latest updates, and features on discontinued projects (if applicable).
This report is built using data and information sourced from Global Markets Direct’s proprietary databases, institute’s website, and featured press releases, both from institute and industry-specific third party sources, put together by Global Markets Direct’s team of industry experts.
Scope
Reasons to buy
Summary
Global Market Direct’s pharmaceuticals report, “The All Ireland Cooperative Oncology Research Group – Developmental Therapeutics Review – Q4 2010” provides data on the institute’s research and development focus. The report includes information on therapeutics under development, complete with latest updates, and features on discontinued projects (if applicable).
This report is built using data and information sourced from Global Markets Direct’s proprietary databases, institute’s website, and featured press releases, both from institute and industry-specific third party sources, put together by Global Markets Direct’s team of industry experts.
Scope
- Review of therapeutics under development by The All Ireland Cooperative Oncology Research Group.
- Overview of products under development across various therapy areas.
- Coverage of therapeutic molecules in various stages of drug development, including the combination treatment modalities, across the globe.
- Product profiles for late stage and clinical stage products of The All Ireland Cooperative Oncology Research Group with complete description of the product’s developmental history, mechanism of action, therapeutic class, target and major milestones.
- Recent updates of The All Ireland Cooperative Oncology Research Group’s therapeutic products in the last quarter.
- Latest news and deals relating to the products.
Reasons to buy
- Identify new drug targets and therapeutic classes in The All Ireland Cooperative Oncology Research Group’s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas.
- Exploit in-licensing opportunities by identifying opportunities to fill portfolio gaps.
- Evaluate The All Ireland Cooperative Oncology Research Group’s position with total access to a detailed information on its therapeutic products development.
- Assess the growth potential of The All Ireland Cooperative Oncology Research Group in its therapy areas of focus.
- Exploit collaboration and partnership opportunities with The All Ireland Cooperative Oncology Research Group.
- Avoid Intellectual Property Rights related issues.
The All Ireland Cooperative Oncology Research Group Snapshot
The All Ireland Cooperative Oncology Research Group Overview
Key Information
Key Facts
The All Ireland Cooperative Oncology Research Group – Research and Development Overview
Key Therapeutic Areas
The All Ireland Cooperative Oncology Research Group – Pipeline Review
Pipeline Products by Stage of Development
Pipeline Products – Monotherapy
Pipeline Products – Combination Treatment Modalities
The All Ireland Cooperative Oncology Research Group – Pipeline Products Glance
The All Ireland Cooperative Oncology Research Group – Late Stage Pipeline
Phase III Products/Combination Treatment Modalities
The All Ireland Cooperative Oncology Research Group Clinical Stage Pipeline Products
Phase II Products/Combination Treatment Modalities
Phase I Products/Combination Treatment Modalities
The All Ireland Cooperative Oncology Research Group – Drug Profiles
Exemestane + Triptorelin + Triptorelin Pamoate + Radiation Therapy
Product Description
Mechanism of Action
R&D Progress
Tamoxifen Citrate + Triptorelin + Triptorelin Pamoate + Radiation Therapy
Product Description
Mechanism of Action
R&D Progress
bortezomib
Product Description
Mechanism of Action
R&D Progress
capecitabine + epirubicin hydrochloride + oxaliplatin
Product Description
Mechanism of Action
R&D Progress
Docetaxel + Oxaliplatin
Product Description
Mechanism of Action
R&D Progress
Epirubicin + Oxaliplatin + Capecitabine
Product Description
Mechanism of Action
R&D Progress
Epirubicin Hydrochloride + Sulindac
Product Description
Mechanism of Action
R&D Progress
Fludarabine + Cyclophosphamide + Rituximab + Pegfilgrastim
Product Description
Mechanism of Action
R&D Progress
Lapatinib ditosylate + Capecitabine
Product Description
Mechanism of Action
R&D Progress
Nilotinib
Product Description
Mechanism of Action
R&D Progress
Oxaliplatin + Docetaxel
Product Description
Mechanism of Action
R&D Progress
Oxaliplatin + Epirubicin Hydrochloride + Capecitabine
Product Description
Mechanism of Action
R&D Progress
Sorafenib
Product Description
Mechanism of Action
R&D Progress
Lapatinib + Epirubicin
Product Description
Mechanism of Action
R&D Progress
The All Ireland Cooperative Oncology Research Group – Pipeline Analysis
The All Ireland Cooperative Oncology Research Group – Pipeline Products by Therapeutic Class
The All Ireland Cooperative Oncology Research Group Pipeline Products By Target
The All Ireland Cooperative Oncology Research Group – Pipeline Products by Route of Administration
The All Ireland Cooperative Oncology Research Group – Pipeline Products by Molecule Type
The All Ireland Cooperative Oncology Research Group - Dormant Projects
The All Ireland Cooperative Oncology Research Group – Locations And Subsidiaries
Head Office
Appendix
Methodology
Coverage
Secondary Research
Primary Research
Expert Panel Validation
Contact Us
Disclaimer
LIST OF TABLES
The All Ireland Cooperative Oncology Research Group – Pipeline by Therapy Area and Indication, 2010
The All Ireland Cooperative Oncology Research Group – Pipeline by Stage of Development, 2010
The All Ireland Cooperative Oncology Research Group – Monotherapy Products in Pipeline, 2010
The All Ireland Cooperative Oncology Research Group – Combination Treatment Modalities in Pipeline, 2010
The All Ireland Cooperative Oncology Research Group – Phase III, 2010
The All Ireland Cooperative Oncology Research Group - Phase II, 2010
The All Ireland Cooperative Oncology Research Group - Phase I, 2010
The All Ireland Cooperative Oncology Research Group - Pipeline By Therapeutic Class, 2010
The All Ireland Cooperative Oncology Research Group - Pipeline By Target, 2010
The All Ireland Cooperative Oncology Research Group – Pipeline By Route of Administration, 2010
The All Ireland Cooperative Oncology Research Group – Pipeline By Molecule Type, 2010
The All Ireland Cooperative Oncology Research Group - Dormant Developmental Projects, 2010 44
LIST OF FIGURES
The All Ireland Cooperative Oncology Research Group – Pipeline by Therapy Area and Indication, 2010
The All Ireland Cooperative Oncology Research Group – Pipeline by Stage of Development, 2010
The All Ireland Cooperative Oncology Research Group – Monotherapy Products in Pipeline, 2010
The All Ireland Cooperative Oncology Research Group – Combination Treatment Modalities in Pipeline, 2010
The All Ireland Cooperative Oncology Research Group – Pipeline By Therapeutic Class, 2010
The All Ireland Cooperative Oncology Research Group - Pipeline By Target, 2010
The All Ireland Cooperative Oncology Research Group – Pipeline By Route of Administration, 2010
The All Ireland Cooperative Oncology Research Group – Pipeline By Molecule Type, 2010 43
The All Ireland Cooperative Oncology Research Group Overview
Key Information
Key Facts
The All Ireland Cooperative Oncology Research Group – Research and Development Overview
Key Therapeutic Areas
The All Ireland Cooperative Oncology Research Group – Pipeline Review
Pipeline Products by Stage of Development
Pipeline Products – Monotherapy
Pipeline Products – Combination Treatment Modalities
The All Ireland Cooperative Oncology Research Group – Pipeline Products Glance
The All Ireland Cooperative Oncology Research Group – Late Stage Pipeline
Phase III Products/Combination Treatment Modalities
The All Ireland Cooperative Oncology Research Group Clinical Stage Pipeline Products
Phase II Products/Combination Treatment Modalities
Phase I Products/Combination Treatment Modalities
The All Ireland Cooperative Oncology Research Group – Drug Profiles
Exemestane + Triptorelin + Triptorelin Pamoate + Radiation Therapy
Product Description
Mechanism of Action
R&D Progress
Tamoxifen Citrate + Triptorelin + Triptorelin Pamoate + Radiation Therapy
Product Description
Mechanism of Action
R&D Progress
bortezomib
Product Description
Mechanism of Action
R&D Progress
capecitabine + epirubicin hydrochloride + oxaliplatin
Product Description
Mechanism of Action
R&D Progress
Docetaxel + Oxaliplatin
Product Description
Mechanism of Action
R&D Progress
Epirubicin + Oxaliplatin + Capecitabine
Product Description
Mechanism of Action
R&D Progress
Epirubicin Hydrochloride + Sulindac
Product Description
Mechanism of Action
R&D Progress
Fludarabine + Cyclophosphamide + Rituximab + Pegfilgrastim
Product Description
Mechanism of Action
R&D Progress
Lapatinib ditosylate + Capecitabine
Product Description
Mechanism of Action
R&D Progress
Nilotinib
Product Description
Mechanism of Action
R&D Progress
Oxaliplatin + Docetaxel
Product Description
Mechanism of Action
R&D Progress
Oxaliplatin + Epirubicin Hydrochloride + Capecitabine
Product Description
Mechanism of Action
R&D Progress
Sorafenib
Product Description
Mechanism of Action
R&D Progress
Lapatinib + Epirubicin
Product Description
Mechanism of Action
R&D Progress
The All Ireland Cooperative Oncology Research Group – Pipeline Analysis
The All Ireland Cooperative Oncology Research Group – Pipeline Products by Therapeutic Class
The All Ireland Cooperative Oncology Research Group Pipeline Products By Target
The All Ireland Cooperative Oncology Research Group – Pipeline Products by Route of Administration
The All Ireland Cooperative Oncology Research Group – Pipeline Products by Molecule Type
The All Ireland Cooperative Oncology Research Group - Dormant Projects
The All Ireland Cooperative Oncology Research Group – Locations And Subsidiaries
Head Office
Appendix
Methodology
Coverage
Secondary Research
Primary Research
Expert Panel Validation
Contact Us
Disclaimer
LIST OF TABLES
The All Ireland Cooperative Oncology Research Group – Pipeline by Therapy Area and Indication, 2010
The All Ireland Cooperative Oncology Research Group – Pipeline by Stage of Development, 2010
The All Ireland Cooperative Oncology Research Group – Monotherapy Products in Pipeline, 2010
The All Ireland Cooperative Oncology Research Group – Combination Treatment Modalities in Pipeline, 2010
The All Ireland Cooperative Oncology Research Group – Phase III, 2010
The All Ireland Cooperative Oncology Research Group - Phase II, 2010
The All Ireland Cooperative Oncology Research Group - Phase I, 2010
The All Ireland Cooperative Oncology Research Group - Pipeline By Therapeutic Class, 2010
The All Ireland Cooperative Oncology Research Group - Pipeline By Target, 2010
The All Ireland Cooperative Oncology Research Group – Pipeline By Route of Administration, 2010
The All Ireland Cooperative Oncology Research Group – Pipeline By Molecule Type, 2010
The All Ireland Cooperative Oncology Research Group - Dormant Developmental Projects, 2010 44
LIST OF FIGURES
The All Ireland Cooperative Oncology Research Group – Pipeline by Therapy Area and Indication, 2010
The All Ireland Cooperative Oncology Research Group – Pipeline by Stage of Development, 2010
The All Ireland Cooperative Oncology Research Group – Monotherapy Products in Pipeline, 2010
The All Ireland Cooperative Oncology Research Group – Combination Treatment Modalities in Pipeline, 2010
The All Ireland Cooperative Oncology Research Group – Pipeline By Therapeutic Class, 2010
The All Ireland Cooperative Oncology Research Group - Pipeline By Target, 2010
The All Ireland Cooperative Oncology Research Group – Pipeline By Route of Administration, 2010
The All Ireland Cooperative Oncology Research Group – Pipeline By Molecule Type, 2010 43
